GCM
IDXX icon

Gallacher Capital Management’s Idexx Laboratories IDXX Stock Holding History

Gallacher Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
476
-184
-28% -$103K 0.14% 222
2026
Q1 		$371K Buy
+660
New +$423K 0.14% 195

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Gallacher Capital Management's IDXX Position: Q2 2026 in Review

Gallacher Capital Management reduced its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, selling an estimated $103K and leaving 476 shares worth $251K. The position accounts for 0.14% of the portfolio, ranked #222.

Gallacher Capital Management first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $371K in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Gallacher Capital Management held 476 shares of Idexx Laboratories worth $251K as of Q2 2026.
  • Gallacher Capital Management sold 184 Idexx Laboratories shares in Q2 2026, an estimated $103K.
  • Idexx Laboratories made up 0.14% of Gallacher Capital Management's portfolio in Q2 2026, its #222 holding.
  • Gallacher Capital Management first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Gallacher Capital Management's Idexx Laboratories position peaked at $371K in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.